These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25771090)
1. [Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study]. Font C; Carmona-Bayonas A; Plasencia JM; Calvo-Temprano D; Sánchez M; Jiménez-Fonseca P; Beato C; Biosca M; Vicente V; Otero R; Med Clin (Barc); 2015 Jan; 144 Suppl 1():31-7. PubMed ID: 25771090 [TBL] [Abstract][Full Text] [Related]
2. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index. Carmona-Bayonas A; Jiménez-Fonseca P; Font C; Fenoy F; Otero R; Beato C; Plasencia JM; Biosca M; Sánchez M; Benegas M; Calvo-Temprano D; Varona D; Faez L; de la Haba I; Antonio M; Madridano O; Solis MP; Ramchandani A; Castañón E; Marchena PJ; Martín M; Ayala de la Peña F; Vicente V Br J Cancer; 2017 Apr; 116(8):994-1001. PubMed ID: 28267709 [TBL] [Abstract][Full Text] [Related]
3. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy. Maestre A; Trujillo-Santos J; Riera-Mestre A; Jiménez D; Di Micco P; Bascuñana J; Vela JR; Peris L; Malfante PC; Monreal M; Ann Am Thorac Soc; 2015 Aug; 12(8):1122-9. PubMed ID: 26114586 [TBL] [Abstract][Full Text] [Related]
4. Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients. Font C; Carmona-Bayonas A; Fernández-Martinez A; Beato C; Vargas A; Gascon P; Otero R J Natl Compr Canc Netw; 2014 Mar; 12(3):365-73. PubMed ID: 24616542 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer. Li X; Hu Y; Lin P; Zhang J; Tang Y; Yi Q; Liang Z; Zhou H; Wang M Thromb Haemost; 2021 Jun; 121(6):834-844. PubMed ID: 33450779 [TBL] [Abstract][Full Text] [Related]
6. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M; Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849 [TBL] [Abstract][Full Text] [Related]
7. Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. Ahn S; Cooksley T; Banala S; Buffardi L; Rice TW Support Care Cancer; 2018 Oct; 26(10):3601-3607. PubMed ID: 29725804 [TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. den Exter PL; Hooijer J; Dekkers OM; Huisman MV J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690 [TBL] [Abstract][Full Text] [Related]
9. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Jiménez D; Kopecna D; Tapson V; Briese B; Schreiber D; Lobo JL; Monreal M; Aujesky D; Sanchez O; Meyer G; Konstantinides S; Yusen RD; On Behalf Of The Protect Investigators Am J Respir Crit Care Med; 2014 Mar; 189(6):718-26. PubMed ID: 24471575 [TBL] [Abstract][Full Text] [Related]
10. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Laporte S; Mismetti P; Décousus H; Uresandi F; Otero R; Lobo JL; Monreal M; Circulation; 2008 Apr; 117(13):1711-6. PubMed ID: 18347212 [TBL] [Abstract][Full Text] [Related]
11. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism. Carmona-Bayonas A; Font C; Jiménez-Fonseca P; Fenoy F; Otero R; Beato C; Plasencia J; Biosca M; Sánchez M; Benegas M; Calvo-Temprano D; Varona D; Faez L; Vicente MA; de la Haba I; Antonio M; Madridano O; Ramchandani A; Castañón E; Marchena PJ; Martínez MJ; Martín M; Marín G; Ayala de la Peña F; Vicente V; Thromb Res; 2016 Jul; 143():76-85. PubMed ID: 27208461 [TBL] [Abstract][Full Text] [Related]
12. Which patients with venous thromboembolism are at risk for fatal pulmonary embolism? Gallus A Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):604-5. PubMed ID: 18679380 [TBL] [Abstract][Full Text] [Related]
13. Cancer-associated unsuspected pulmonary embolism. van Es N; Bleker SM; Di Nisio M Thromb Res; 2014 May; 133 Suppl 2():S172-8. PubMed ID: 24862140 [TBL] [Abstract][Full Text] [Related]
14. Keeping prognostic assessment simple: The value of clinical features in normotensive cancer patients with pulmonary embolism. Moura Ferreira J; Moura-Ferreira S; Baptista R; Ferreira R; Madaleno J; Silva N; Ferreira MJ; Pego M Rev Port Cardiol (Engl Ed); 2019 Jun; 38(6):407-415. PubMed ID: 31307728 [TBL] [Abstract][Full Text] [Related]
15. Validation of two clinical prognostic models in patients with acute symptomatic pulmonary embolism. Ferrer M; Morillo R; Elías T; Jara L; García L; Nieto R; Sandoval E; Uresandi F; Otero R; Jiménez D Arch Bronconeumol; 2013 Oct; 49(10):427-31. PubMed ID: 23664248 [TBL] [Abstract][Full Text] [Related]
16. Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Kline JA; Roy PM; Than MP; Hernandez J; Courtney DM; Jones AE; Penaloza A; Pollack CV Thromb Res; 2012 May; 129(5):e194-9. PubMed ID: 22475313 [TBL] [Abstract][Full Text] [Related]
17. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. den Exter PL; Gómez V; Jiménez D; Trujillo-Santos J; Muriel A; Huisman MV; Monreal M; Chest; 2013 Jan; 143(1):138-145. PubMed ID: 22814859 [TBL] [Abstract][Full Text] [Related]